Pierre‐Marie Boutanquoi
Inserm · 18 works · 172 citations · h-index 5
Top works
- TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling
- DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residues
- Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin
- A novel fatty acid analogue triggers CD36–GPR120 interaction and exerts anti-inflammatory action in endotoxemia
- HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling
- An antisense oligonucleotide targeting the heat‐shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis
- Correction: DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residues
- Traitement de la fibrose pulmonaire idiopathique : Rôle de TRIM33 et de l’inhibition d’HSPB5
- An antisense oligonucleotide targeting HSPB5 as an innovating therapeutic approach in pulmonary fibrosis
- NCI-41356, a promising molecule in idiopathic pulmonary fibrosis?
- TIF1? has a protective role in pulmonary fibrosis
- Inhiber HSPB5 pour traiter la fibrose pulmonaire idiopathique : vers une nouvelle stratégie thérapeutique ?
- TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis
- Role of extracellular HSP27 in idiopathic pulmonary fibrosis (IPF)
- P087 Inhibition of pleural inflammation hampers with bleomycin-induced lung profibrotic toxicity.
- NCI-41356, a promising small inhibitor of HSPB5 in idiopathic pulmonary fibrosis?
- LSC - 2019 - TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis
- Role of Extracellular HSP27 in pulmonary fibrosis